NorthView Acquisition Corporation
NVAC
$12.10
$0.050.42%
| Weiss Ratings | NVAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | D+ | |||
| Rating Factors | NVAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | NVAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.09 | |||
| Price History | NVAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 1.42% | |||
| 60-Day Total Return | 3.33% | |||
| 90-Day Total Return | 3.33% | |||
| Year to Date Total Return | 3.33% | |||
| 1-Year Total Return | 7.36% | |||
| 2-Year Total Return | 17.02% | |||
| 3-Year Total Return | 23.22% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -6.92% | |||
| 52-Week Low % Change | 6.98% | |||
| Price | NVAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $13.00 | |||
| 52-Week Low Price | $11.31 | |||
| 52-Week Low Price (Date) | Apr 17, 2024 | |||
| 52-Week High Price (Date) | May 21, 2024 | |||
| Valuation | NVAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 71.16M | |||
| Enterprise Value | 80.06M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.15 | |||
| Earnings Per Share Growth | -225.70% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -13.75 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $12.10 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -48.46 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | NVAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 5.93M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NVAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 212 494 9022 | |||
| Address | 207 West 25th Street New York, NY 10001 | |||
| Website | -- | |||
| Country | United States | |||
| Year Founded | 2021 | |||
| Profitability | NVAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | NVAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -9.58% | |||
| Return on Equity | -- | |||
| Income Statement | NVAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -1.50M | |||
| Net Income (TTM) | -890.60K | |||
| Net Income Avl. to Common (TTM) | -890.60K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 124.83% | |||
| EPS Diluted (TTM) | -0.15 | |||
| EPS Diluted Growth (Q YOY) | 125.84% | |||
| Balance Sheet | NVAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 500.00 | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 681.90K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -5.18M | |||
| Current Ratio (Q) | 0.132 | |||
| Book Value Per Share (Q) | -$0.88 | |||
| Total Assets (Q) | 8.78M | |||
| Total Current Liabilities (Q) | 5.17M | |||
| Total Debt (Q) | 1.59M | |||
| Total Liabilities (Q) | 13.96M | |||
| Total Common Equity (Q) | -5.18M | |||
| Cash Flow | NVAC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 2.43M | |||
| Cash from Financing (TTM) | -1.14M | |||
| Net Change in Cash (TTM) | -16.80K | |||
| Levered Free Cash Flow (TTM) | -308.00K | |||
| Cash from Operations (TTM) | -1.31M | |||
